Meihua International Medical Technologies Co., Ltd. (MHUA)
USD 0.33
(2.47%)
USD 0.33
(2.47%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -9.59 Million USD | 51.83% |
| 2022 | -19.92 Million USD | -570.59% |
| 2021 | -2.97 Million USD | 25.15% |
| 2020 | -3.96 Million USD | 70.48% |
| 2019 | -13.44 Million USD | -5.31% |
| 2018 | -12.76 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -6.72 Million USD | 0.0% |
| 2024 Q1 | -6.72 Million USD | 29.93% |
| 2023 Q4 | -9.59 Million USD | 0.03% |
| 2023 Q1 | -10.69 Million USD | 46.34% |
| 2023 FY | -9.59 Million USD | 51.83% |
| 2023 Q3 | -9.59 Million USD | 10.21% |
| 2023 Q2 | -10.69 Million USD | 0.0% |
| 2022 Q4 | -19.92 Million USD | 0.0% |
| 2022 Q3 | -19.92 Million USD | 30.44% |
| 2022 FY | -19.92 Million USD | -570.59% |
| 2022 Q2 | -28.64 Million USD | 0.0% |
| 2022 Q1 | -28.64 Million USD | -864.08% |
| 2021 Q1 | -2.1 Million USD | 46.93% |
| 2021 FY | -2.97 Million USD | 25.15% |
| 2021 Q4 | -2.97 Million USD | 0.0% |
| 2021 Q2 | -2.1 Million USD | 0.0% |
| 2021 Q3 | -2.97 Million USD | -41.04% |
| 2020 Q3 | -3.96 Million USD | 25.5% |
| 2020 Q4 | -3.96 Million USD | 0.0% |
| 2020 Q2 | -5.32 Million USD | 0.0% |
| 2020 Q1 | -5.32 Million USD | 60.38% |
| 2020 FY | -3.96 Million USD | 70.48% |
| 2019 Q1 | 14.8 Million USD | 0.0% |
| 2019 FY | -13.44 Million USD | -5.31% |
| 2019 Q4 | -13.44 Million USD | 0.0% |
| 2019 Q3 | -13.44 Million USD | 0.0% |
| 2018 FY | -12.76 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | 471.784% |
| AngioDynamics, Inc. | -70.14 Million USD | 86.32% |
| AtriCure, Inc. | -9.81 Million USD | 2.244% |
| Avinger, Inc. | 10.12 Million USD | 194.82% |
| Azenta, Inc. | -618.47 Million USD | 98.448% |
| BioLife Solutions, Inc. | 7.25 Million USD | 232.3% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 100.392% |
| Daxor Corporation | 755.65 Thousand USD | 1369.851% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | -552.772% |
| Femasys Inc. | -15.01 Million USD | 36.093% |
| GlucoTrack, Inc. | -4.29 Million USD | -123.365% |
| Harvard Bioscience, Inc. | 38.49 Million USD | 124.93% |
| Hologic, Inc. | 374.4 Million USD | 102.563% |
| ICU Medical, Inc. | 1.45 Billion USD | 100.662% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 99.639% |
| KORU Medical Systems, Inc. | -7.03 Million USD | -36.359% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | -85.461% |
| Innovative Eyewear, Inc. | -4.28 Million USD | -123.81% |
| Innovative Eyewear, Inc. | -4.28 Million USD | -123.81% |
| Masimo Corporation | 804 Million USD | 101.194% |
| Microbot Medical Inc. | -2.28 Million USD | -319.761% |
| Merit Medical Systems, Inc. | 302.22 Million USD | 103.175% |
| Nephros, Inc. | -2.47 Million USD | -288.334% |
| NovoCure Limited | 355.42 Million USD | 102.7% |
| NEXGEL, Inc. | 98 Thousand USD | 9891.576% |
| NEXGEL, Inc. | 98 Thousand USD | 9891.576% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | 116.249% |
| OraSure Technologies, Inc. | -276.9 Million USD | 96.535% |
| Pro-Dex, Inc. | 10.91 Million USD | 187.905% |
| Pulse Biosciences, Inc. | -35.22 Million USD | 72.756% |
| Predictive Oncology Inc. | -5.87 Million USD | -63.42% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | 416.777% |
| QuidelOrtho Corporation | 2.49 Billion USD | 100.385% |
| Repligen Corporation | -39.51 Million USD | 75.719% |
| Sanara MedTech Inc. | 6.64 Million USD | 244.408% |
| STAAR Surgical Company | -147.2 Million USD | 93.481% |
| Sharps Technology, Inc. | -3.01 Million USD | -218.488% |
| Utah Medical Products, Inc. | -92.52 Million USD | 89.629% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 100.488% |
| Jin Medical International Ltd. | -2.81 Million USD | -240.696% |